Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV005199292 | SCV005839481 | pathogenic | Wilms tumor 1 | 2024-07-01 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln444*) in the GPC3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GPC3 are known to be pathogenic (PMID: 10402475, 12713262, 17603795). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Simpson-Golabi-Behmel syndrome (PMID: 27790374). For these reasons, this variant has been classified as Pathogenic. |